Cells of the immune system are replaced in large numbers throughout life, and the underlying mechanisms have been extensively studied. Whereas the pace of discovery in this area is unprecedented, many questions remain, particularly with respect to lymphocyte formation.
INTRODUCTION
Mechanisms responsible for immune system replenishment have been studied for some time but not with the current level of success. We and others have attempted to capture the essence of that progress, but reviews are incomplete soon after publication [1] [2] [3] [4] . Our last contribution to this series focused on the heterogeneity of hematopoietic stem cells (HSCs), as well as developmental relationships to equally diverse progenitors in the B-lineage lymphoid series [1] ( Fig. 1 ). Since then, notable progress has been made in understanding requisite transcription factors and microRNAs (miRNAs) needed for sustaining T-lymphocyte production and steps in natural killer (NK) cell formation. Molecular mechanisms are being sought that would account for age-related declines in the process, as well as infection-related changes. There has also been success in identification of lymphoid progenitors in humans. This brief review will try to capture some of those developments, emphasizing B lymphopoiesis as representative of all immune system components. expression in multi-potent progenitors (MPPs), thereby inducing B lymphopoiesis indirectly [7] . Ikaros then antagonizes PU.1 by up-regulating Gfi1.
E2A proteins also play critical roles in early lymphoid specification. A recent study indicates that E2A and HEB function in concert to up-regulate the expression of FOXO-1 in CLPs [2] . E2A is likely to bind directly to regulatory elements in the FOXO-1 locus. Deficiency of either E2A or HEB generated similar phenotypes and gene profiles. In both cases, B-cell development was arrested at the Ly6D À CLP stage.
Sequential activation of E2A, Ebf1, Pax5 and FOXO1 is essential for B-lineage differentiation and commitment. However, these transcription factors work in a cross-regulatory network rather than a hierarchical one-way direction. Chromatin immunoprecipitation (ChIP) sequencing studies found coordinated DNA occupancy and interactions between these key transcriptional regulators [8 & ]. Ebf1 and FOXO1 promote B-lineage differentiation in a feed-forward manner [8 & ]. An epigenetic study reported a spectrum of genes that switched nuclear location during early B-cell development [9 && ]. That is, E2A, PU.1, Ebf1 and Pax5 seem to bind 'collaboratively' while regulating B-lineage differentiation. On the contrary, the locus for Ebf1 was sequestered at the nuclear lamina in MPPs to prevent its premature activation.
Ebf1 and Pax5 are both expressed in CLP subsets [1] and largely up-regulated in pro-B cells. They have distinct roles in B-cell differentiation and commitment. Pax5-regulated genes in pro-B cells account for about a quarter of all expression changes when cells proceed from CLP to pro-B cell stages [10 & ]. Sigvardsson and colleagues crossed l5 reporter mice
KEY POINTS
Molecular control of lymphopoiesis is now been studied in terms of epigenetic mechanisms and micro-RNAs.
Differentiation diagrams popular in the past continue to be challenged and refined with surprising new findings.
Rates of production of lymphocytes are, like those for other blood cells, altered by circumstances.
Young healthy HSCs
HSCs: Heterogeneity of hematopoietic stem cells (HSCs). Subsets of HSCs differ in terms of surface marker expression, dye efflux and function. In murine bone marrow, most are defined as Lin À c-Kit þ Sca-1 þ Flt3 À CD34 À CD150 þ CD48 À . Recent studies suggest there are at least three major HSC classes, distinguished according to the spectrum of blood cells they produce. That is, some are relatively balanced, others are biased to produce myeloid cells and still others preferentially generate lymphocytes. Ones with high densities of CD150 tend to be robust and myeloid biased. Additional variability relates to cell cycle status and potential for marrow engraftment on transplantation, as well as the kinetics and duration of blood cell formation. Stem cells can change with respect to composition and properties as a result of normal aging and during chronic infectious disease. Lymphoid progenitors arising from these HSCs are themselves heterogeneous and acquire B-cell properties in an asynchronous manner. Reproduced with permission from [1] . ]. Progenitor cells with low levels of Pax5 developed a hybrid B-lymphoid/myeloid phenotype, B220 þ CD19 À CD11b þ Gr-1 À . FOXO family members enhance the expression of IL-7 receptors, by which signaling results in activation of FOXO1, suggesting a positive feedback loop in their action for B-lineage determination. Since FOXO1 is a direct target of Ebf1 and E2A, the family might act downstream of the two indispensable factors for the B lineage [13, 14] .
Additional transcription factors have been added to the network. c-Myc regulates cell proliferation, survival and more importantly, expression of Ebf1 [15] . c-Myb appears to act upstream of Ebf1 and regulate survival and differentiation of pro-B cells. Whereas c-Myb regulates the expression of IL-7 receptors, the molecule affects pro-B cell survival independent of IL-7 receptor signaling [16, 17] . Runx1 is indispensable for the development of authentic HSCs responsible for definitive hematopoiesis. Loss of Runx1 or its binding partner Cbfb caused a developmental block in early B-lineage differentiation [18 & ]. Expression of E2A, Ebf and Pax5 was reduced in the Runx1-deficient progenitors. Runx1-Cbfb complexes were found to bind the Ebf1 promoter, and Runx1 deletion caused excessive H3K27 trimethylation, which usually suppresses transcription, in the Ebf1 promoter region. ATP11C is a P4-type ATPase. Mice with ATP11C deficiency had diminished follicular B cells. Available data suggest ATP11C is responsible for maintaining progenitors' responsiveness to IL-7 and the level of Ebf1 [19] . Bcl11a deficiency selectively reduced HSCs, all lymphocytes and their progenitors [20 & ]. This is partially due to the antiapoptotic activity of Bcl11a. It is also required for lymphopoiesis from HSCs and lymphoid-primed multipotent progenitors (LMPPs) via mechanisms that do not involve Ikaros, E2A or Ebf1.
ROLES FOR MICRORNAs
Many miRNAs are expressed in HSCs and progenitor cells ( Fig. 2 ). They are important post-transcriptional regulators of gene expression that inhibit messenger RNA (mRNA) translation and induce RNA degradation. Dicer is a ribonuclease needed for miRNA generation, and Dicer gene ablation first established their importance for lymphopoiesis [21] . Ectopic expression of miR-181 increased lymphocyte numbers, whereas the opposite resulted from miR-150 overexpression. Reciprocally, loss of miR-150 resulted in selective expansion of B1 cells [22] . These findings showed that miR-150 may function as a negative regulator of B lymphopoiesis and play a role in B1 and B2 fate decisions.
MiR-125b is mostly expressed in HSCs; overexpression caused lymphoid-biased HSCs and increased peripheral lymphocytes [23] . This suggests that miR-125b may contribute to HSC heterogeneity and early lymphoid priming. Kuchen et al. [24] performed comprehensive miRNA, mRNA and ChIP-sequencing on various hematopoietic cells. They found miRNAs that are exclusively expressed in B lymphocytes and showed that miRNA expression was epigenetically regulated. This study only focused on B-lineage differentiation stages after proB cells. Information of miRNA abundance and regulation during early lymphopoiesis such as early lymphoid progenitor (ELP) and CLP stages could be very valuable.
Roles are also being found for miRNAs in T-lineage differentiation. As just one example, deep miRNA and ChIP-sequencing of cells from ]. Some miRNAs that were abundant in bone marrow precursors were downregulated up to three-fold in thymic T-cell progenitors, whereas levels of other miRNAs were increased.
REPLENISHING THE THYMUS
T lymphocytes are derived from HSCs, but no HSCs are present in the thymus, and HSCs do not home to that organ when transplanted to normal, un-irradiated recipients. It was long believed that the thymus needs constant replenishment by bone marrow progenitors to make T cells. Those observations drove intensive effort to identify and characterize those progenitors. However, two interesting studies showed that double negative stage progenitors resident in the thymus can sustain T lymphopoiesis for months, provided they face no competition from similar cells that are competent to respond to the cytokine IL-
The experimental designs involved transplantation of wild-type thymuses to immunodeficient Rag2 À/À gc À/À Kit w/w , Rag2 À/À gc À/À or IL-7Ra À/À recipients with the surprising result that newly formed T cells were exported for some time. When the recipient mice were Kit w/w , Rag2 À/À , the thymocytes were all replaced by host cells as expected. Competition among early progenitors had previously been appreciated by Prockop and Petrie [28].
The already difficult task of defining which marrow progenitors are most important for replenishing the thymus was made harder by these important results. However, much can be learned by comparison of the most primitive thymocytes to possible thymus seeding cells within the bone marrow. That was achieved by Jacobsen and colleagues. Elegant single cell experiments revealed that early thymic progenitors resembled marrow equivalents with respect to gene expression patterns and differentiation potential [29 && ]. In both cases, loss of megakaryocyte-erythrocyte production occurred before myeloid, T and B lineage repopulating functions. This adds support to the 'myeloid'-based model long championed by Kawamoto et al. ] used a variety of approaches to conclude that early thymocyte progenitors are a major source of granulocytes in the thymus.
NEW INFORMATION CONCERNING NATURAL KILLER CELL GENERATION
Like other lymphocytes, NK cell formation is marked by sequential acquisition of mature cell markers [32] . NK progenitors in bone marrow were previously defined as CD122(IL-2Rb) þ NK1.1 À CD49b À , but more primitive ones were described in two recent reports. Since the ID2 transcription factor is essential for NK production, Carotta et al. [33] exploited an ID2-GFP reporter to identify prepro NK cells with NK, but not B and T differentiation potential. They lacked Flt3, had distinctly highdensity IL-7Ra and, with the exception of CD244 and NKG2D, lacked mature NK cell markers. Two subsets of prepro NK cells were distinguished by levels of c-Kit, which were functionally similar. Given their high expression of IL-7Ra and lineage restriction, it is likely that prepro NK cells represent relatively late-stage CLPs. An overlapping population of NK progenitors was identified with a different strategy [34] . It is interesting that these bone marrow-derived cells could produce NK cells on transplantation, but not when injected into the thymus. This supports the idea that NK cells are also formed in other sites and possibly via multiple differentiation pathways [35] . In addition to ID2, Bcl11a deletion affects NK development as well as T and B cells. Interestingly, Bcl11a is expressed only in prepro NKa and CD122 þ NKP but not NKb progenitors, suggesting it might distinguish two different NK subsets [20 & ].
AGE-RELATED CHANGES AND MECHANISMS
Diminished lymphopoietic potential of HSCs occurs as a function of age. As covered elsewhere in this volume and in our previous review, it is accompanied by altered ratios between HSC subsets ( Fig. 1 ) [1, 36] . Recent studies of the underlying mechanisms suggest that there are likely to be environmental as well as HSC-intrinsic changes. High-resolution methods are now available for locating stem/progenitor cells within bone marrow sections. Exploitation of that approach revealed that aged HSCs localize more distantly from endosteal areas than young HSCs [37] . As another possible example of environment and competition for space within lymphopoietic niches, depletion of longlived mature B lymphocytes induced expansion of HSCs as well as CLPs in the aged bone marrow [38] .
Despite many years of investigation, it remains unclear how telomere dysfunction relates to aging in the lympho-hematopoietic system. Suda and colleagues studied ataxia-telangiectasia-mutated mice where premature aging is induced through accumulation of reactive oxygen species. Telomerase activity protected HSCs from age-related phenotypes, but did not affect the telomere length [39] . Whereas telomere shortening was reported to induce functional exhaustion in HSCs in a cellautonomous manner [40] , telomere dysfunction in systemic environments may be more relevant to the age-related impairment of lymphopoiesis [41] . Also, the basic leucine zipper transcription factor, ATF-like (BATF), was found to play an intermediary role for telomere attrition and DNA damage in HSCs [42] . Once telomere dysfunction or DNA damage occurred in HSCs, the induced BATF limited self-renewing proliferation. It also skewed their differentiation into CD150 Lo lymphoid-biased HSCs. Interestingly, BATF transcripts and protein are increased in aged HSCs whose potential is highly myeloid-biased. This discrepancy may suggest that, whereas BATF protects aged HSCs from myelogenous dysplasia, aging affects more profoundly the lineage potential of HSCs independent of telomere attrition.
RhoGTPase Cdc42 regulates cell polarity by modifying actin and tubulin organization. Geiger and colleagues found that increased activity of Cdc42 in aged HSCs paralleled loss of cell polarity [43 & ]. Mice lacking RhoGAP protein, a highly selective inhibitor of Cdc activity, exhibited premature hematopoietic aging phenotype, that is an increase of myeloid cells and a decrease of T and B lymphocytes. Importantly, treatment of aged HSCs with a selective Cdc42 inhibitor restored not only HSC polarity but also their lymphopoietic potential [43 & ]. As methods for monitoring epigenetic regulation become more routinely used, evidence is accumulating to explain age-related changes [44] . In that regard, it is noteworthy that pharmacological manipulation of Cdc42 activity reverted levels and patterns of histone H4 acetylation of aged HSCs to those of young HSCs [43 & ]. It is interesting to consider that specific histone methylation and/or acetylation events might someday represent therapeutic targets.
ALTERED PATTERNS DURING INFECTIONS
Hematopoietic stem cells and progenitors express pathogen-associated receptors (PPRs) such as Tolllike, RIG I-like, Nod-like, and purinergic receptors [45, 46] . Although those receptors serve to sense components of bacteria, viruses, and fungi, they may also detect endogenous ligands to elicit innate immunity. Accumulating evidence suggests these molecules can induce extramedullary hematopoiesis, migration of lymphoid progenitors, and depletion of lymphopoiesis within marrow. Other features include myeloid skewing of hematopoiesis, as well as exhaustion, cell cycle progression, and deficient homing of HSCs [1] . Whereas hematopoietic cells can directly respond to pathogen products, their properties are also influenced by inflammatory cytokines such as TNFa, IFNa, IFNg, and IL-6, but not IL-1b [1, 47] . The relative importance of direct versus indirect recognition of such substances is likely to depend on pathogens and routes of administration [47,48 & ]. The aryl hydrocarbon receptor (AHR) is a member of the basic helix loop helix family of transcription factors that merits further study in connection with hematopoiesis. A screen revealed that a small molecule promoted human HSC survival and xenotransplantation by antagonizing AHR [49] . In contrast, the AHR ligand 2,3,7,8tetrachlorodibenzodioxin increased numbers and proliferation of HSCs, while compromising transplantation efficiency [50] .
Purinergic receptors that sense extracellular nucleotides such as ATP, UTP and adenosine can evoke systemic immune responses. Interestingly, administration of ATP induced HSC proliferation and diminished their long-term repopulation potential [51] . These responses depended on Ca 2þ signaling and were blocked by treatment in culture with myelopoietic cytokines. This is certain to be a fertile area of exploration, with implications for immune defense, cancer, and regeneration of lymphopoiesis following myeloablation or transplantation.
INITIATION OF LYMPHOPOIESIS IN HUMANS
Studies of lymphopoiesis in humans, as with mice, have been unnecessarily complicated by nomenclature problems. For example, cells with distinctly different characteristics are referred to by the same name, and flow cytometry definitions evolve with time. Also, proprietary names are given to progenitors previously described by others. Added to this difficulty is the problem of efficiently observing human lymphocyte formation with culture or transplantation approaches. Nonetheless, significant progress is now being made in identifying human lymphoid progenitors (Fig. 3) . IL-7 is essential for B lymphopoiesis in mice. Multiple studies agree that secondary up-regulation of Ebf1 in response to IL-7 is essential for progression in the B-lymphocyte lineage [56] . Further refinement showed that a relatively mature, Ly6D þ subset subset of CLPs is particularly IL-7-dependent [56] . Unlike the situation in mice, IL-7 is neither required nor sufficient for human B lymphopoiesis. Furthermore, the IL-7R cannot be used as a marker for human B-cell progenitors, and other milestones must be identified [52] .
Among progenitors isolated from human cord blood, CD7 expressing CD34 þ cells exhibit the most T-lymphocyte potential. CD10 is present on ones potent at generating B lymphocytes and is helpful for identifying the human equivalents of CLPs [52] . However, we found that cord blood and bone marrow progenitor cells express a wide range of CD10 densities. Increased levels correspond to more B-lineage commitment and loss of ability to expand in culture [54] . Another study reported that CD34 þ CD45RA þ CD10 À multipotent progenitor cells from human cord blood could generate B cells without going through the CD10 þ CLP stage, suggesting multiple pathways of human B lymphopoiesis [57] .
Dick and colleagues developed improved single cell culture assays for human progenitors [55] . Using this tool, they identified Thy1 -CD45RA þ multilineage progenitors (MLPs) among the CD34 þ CD38 -Lin À fractions in cord blood and bone marrow. Similar to ELPs/LMPPs first discovered in mice [58, 59] , MLPs gave rise to B, T, NK, and dendritic cells, as well as macrophages, but lacked granulocyte and erythroid potential. They also used a xenotransplantation model to evaluate multilineage potential. Cord blood-derived MLPs generated CD19 þ B cells, CD33 þ granulocytes, CD14 þ monocytes, and CD15 þ granulocytes, but not T cells. Interestingly, some patients with monocytopenia lack phenotypic MLPs as well as B, NK, and dendritic cells, but do have T lymphocytes [60] .
Others studied segregation of intermediate FIGURE 3 . A comparison of B lymphopoiesis in humans and mice. Whereas milestones of murine lymphopoiesis have been identified with many markers, it has been difficult to obtain comparable information for humans [52] . As one major complication, none of the cell surface proteins are expressed in conserved fashion. For example, CD10 instead of IL-7Ra is useful for defining human CLPs. A recent study showed that human CD62L þ CD10 À progenitors have myeloid and lymphoid, but not erythroid or megakaryocyte potential [53 & ]. They can give rise to CD10 þ CLPs in culture, suggesting they are similar to mouse LMPPs/ELPs. CD10 density increases through human B lymphopoiesis and CD10 Hi CLPs may be equivalent to Ly6D þ CLPs in mice [54] . Patterns of CD45RA and CD10 expression help to delineate a relatively primitive form of CLP [55] . Similar to the case in mice, human progenitors do not acquire markers in completely synchronous fashion and differentiate in a simple linear manner. However, complete loss of nonlymphoid potential appears to be a very late event in humans as compared to mice. MLP, multilymphoid progenitor. may be marked by asynchronous patterns of gene expression as is the case for mice [1] , but solid progress is being made in identifying those events.
CONCLUSION
Much has happened in the short interval since our last review [1] , and this update still fails to mention some important findings. Even so, it is possible to see that microRNAs and epigenetic regulation will gain increased attention in connection with lymphopoiesis. Age-related declines in the process are now being effectively probed and may eventually be reversed. We already know that cytokine requirements for human and murine lymphocyte formation are different, as is the case for patterns of cell surface protein expression. Nonetheless, principles learned from experimental animals form a sound basis for dissecting the process in humans.
One overall goal of this study is to have sufficient information to boost lymphocyte replacement during rebound from chemotherapy and transplantation. Another is to appreciate how imbalances occur during malignant and autoimmune diseases. ], a long-held notion was demolished by these findings. The thymus indeed contains primitive progenitors that can extensively self-renew if not displaced by newly arriving ones from the bone marrow.
